InvestSMART

Oakridge International Limited (ASX:OAK)

ALERT: Price-sensitive ASX Announcement for OAK
Current share price for OAK : $0.080 -0.01 (-11.11%)+
Release
30 Jan 2026 3:14PM
Price at Release
$0.090
Full Release
download
Summary
Oakridge International Limited delivered strong performance in the quarter ending December 31, 2025, driven by its healthcare technology sector specializing in nurse call and assistive technology solutions. The company saw solid revenue growth due to consistent customer orders and an increased inventory investment. With the completion of RTLS enablement for its core platform and initial hardware production set for early 2026, Oakridge is poised for further growth. Financially, the company reported a decrease in net operating cash flows but maintained a positive financing activity cash flow. Oakridge is actively exploring additional funding options and anticipates improved cash flows in subsequent quarters.
Key Points
  • Oakridge International Limited reported a solid performance for the quarter ended 31 December 2025.
  • The company specializes in healthcare technology solutions, particularly for nurse call and assistive devices.
  • Revenue for the period was supported by customer orders and investment in inventory.
  • The company completed RTLS enablement for its core platform, with hardware production set for early 2026.
  • Strategic partner relationships were strengthened, supporting national coverage.
  • The project pipeline includes opportunities in Australian healthcare and international markets.
  • Oakridge's financials indicate an increase in cash from financing activities and a decrease from operations.
  • Net cash from operating activities was reported at negative $437,000 for the quarter.
  • Cash and cash equivalents at the end of the period were $151,000.
  • Related party payments during the period amounted to $8,000.
  • The company is evaluating options to raise further cash and expects to increase its net operating cash flows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.